Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
3806 | 1903 | 31.5 | 60% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
51 | 3 | HEMATOLOGY//BONE MARROW TRANSPLANTATION//BLOOD | 91443 |
56 | 2 | MYELODYSPLASTIC SYNDROME//HEMATOLOGY//ACUTE MYELOID LEUKEMIA | 29625 |
3806 | 1 | CYTOSINE ARABINOSIDE//ARA CTP//CYTARABINE | 1903 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | CYTOSINE ARABINOSIDE | authKW | 234495 | 4% | 22% | 67 |
2 | ARA CTP | authKW | 142700 | 1% | 68% | 13 |
3 | CYTARABINE | authKW | 124996 | 3% | 12% | 63 |
4 | ARA C | authKW | 99818 | 2% | 16% | 40 |
5 | URACIL ARABINOSIDE | authKW | 96265 | 0% | 100% | 6 |
6 | ACUTE MYELOID LEUKEMIA | authKW | 70708 | 7% | 3% | 138 |
7 | HIGH DOSE ARA C | authKW | 59061 | 0% | 41% | 9 |
8 | ACUTE MYELOGENOUS LEUKEMIA | authKW | 56973 | 2% | 8% | 46 |
9 | HIGH DOSE CYTARABINE | authKW | 55317 | 1% | 27% | 13 |
10 | MITOXANTRONE | authKW | 49094 | 3% | 6% | 54 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Hematology | 32745 | 40% | 0% | 761 |
2 | Oncology | 23473 | 57% | 0% | 1085 |
3 | Medicine, General & Internal | 461 | 9% | 0% | 167 |
4 | Pharmacology & Pharmacy | 295 | 10% | 0% | 187 |
5 | Pediatrics | 151 | 4% | 0% | 78 |
6 | Transplantation | 119 | 2% | 0% | 39 |
7 | Medicine, Research & Experimental | 8 | 2% | 0% | 39 |
8 | Geriatrics & Gerontology | 8 | 1% | 0% | 12 |
9 | Immunology | 2 | 3% | 0% | 49 |
10 | Cell & Tissue Engineering | 1 | 0% | 0% | 3 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | UNITA LEUCEMIE | 32088 | 0% | 100% | 2 |
2 | AARHUS AMTSYGEHUS | 16044 | 0% | 100% | 1 |
3 | ADULT ONOCL | 16044 | 0% | 100% | 1 |
4 | AML ABORAT GRP SECRETARIAT | 16044 | 0% | 100% | 1 |
5 | ANAT PATOL LARGO F VITO 1 | 16044 | 0% | 100% | 1 |
6 | CHAIR CANADIAN LEUKEMIA STUDIES GRP | 16044 | 0% | 100% | 1 |
7 | CHILDRENS HAMATOL | 16044 | 0% | 100% | 1 |
8 | CHILDRENS HOSP LOS ANGELESSECT CANC PHARMACOL | 16044 | 0% | 100% | 1 |
9 | DIMICHAIR HAEMATOL | 16044 | 0% | 100% | 1 |
10 | EMATOL CTMO A NERI | 16044 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | LEUKEMIA | 38676 | 7% | 2% | 135 |
2 | SEMINARS IN ONCOLOGY | 17258 | 4% | 1% | 75 |
3 | CANCER TREATMENT REPORTS | 14033 | 2% | 2% | 44 |
4 | LEUKEMIA RESEARCH | 13683 | 4% | 1% | 72 |
5 | ONKOLOGIE | 11930 | 2% | 2% | 44 |
6 | LEUKEMIA & LYMPHOMA | 9402 | 4% | 1% | 67 |
7 | MEDICAL AND PEDIATRIC ONCOLOGY | 8266 | 2% | 1% | 36 |
8 | ANNALS OF HEMATOLOGY | 6594 | 2% | 1% | 39 |
9 | CANCER CHEMOTHERAPY AND PHARMACOLOGY | 6067 | 3% | 1% | 53 |
10 | JOURNAL OF CLINICAL ONCOLOGY | 5928 | 4% | 0% | 78 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CYTOSINE ARABINOSIDE | 234495 | 4% | 22% | 67 | Search CYTOSINE+ARABINOSIDE | Search CYTOSINE+ARABINOSIDE |
2 | ARA CTP | 142700 | 1% | 68% | 13 | Search ARA+CTP | Search ARA+CTP |
3 | CYTARABINE | 124996 | 3% | 12% | 63 | Search CYTARABINE | Search CYTARABINE |
4 | ARA C | 99818 | 2% | 16% | 40 | Search ARA+C | Search ARA+C |
5 | URACIL ARABINOSIDE | 96265 | 0% | 100% | 6 | Search URACIL+ARABINOSIDE | Search URACIL+ARABINOSIDE |
6 | ACUTE MYELOID LEUKEMIA | 70708 | 7% | 3% | 138 | Search ACUTE+MYELOID+LEUKEMIA | Search ACUTE+MYELOID+LEUKEMIA |
7 | HIGH DOSE ARA C | 59061 | 0% | 41% | 9 | Search HIGH+DOSE+ARA+C | Search HIGH+DOSE+ARA+C |
8 | ACUTE MYELOGENOUS LEUKEMIA | 56973 | 2% | 8% | 46 | Search ACUTE+MYELOGENOUS+LEUKEMIA | Search ACUTE+MYELOGENOUS+LEUKEMIA |
9 | HIGH DOSE CYTARABINE | 55317 | 1% | 27% | 13 | Search HIGH+DOSE+CYTARABINE | Search HIGH+DOSE+CYTARABINE |
10 | MITOXANTRONE | 49094 | 3% | 6% | 54 | Search MITOXANTRONE | Search MITOXANTRONE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | LEOPOLD, LH , WILLEMZE, R , (2002) THE TREATMENT OF ACUTE MYELOID LEUKEMIA IN FIRST RELAPSE: A COMPREHENSIVE REVIEW OF THE LITERATURE.LEUKEMIA & LYMPHOMA. VOL. 43. ISSUE 9. P. 1715-1727 | 85 | 74% | 71 |
2 | THOMAS, X , ARCHIMBAUD, E , (1995) INFUSIONAL CYTOSINE-ARABINOSIDE ADMINISTRATION FOR THE TREATMENT OF ADULT ACUTE MYELOID-LEUKEMIA.BULLETIN DU CANCER. VOL. 82. ISSUE 11. P. 911-922 | 76 | 71% | 3 |
3 | HEINEMANN, V , JEHN, U , (1990) RATIONALES FOR A PHARMACOLOGICALLY OPTIMIZED TREATMENT OF ACUTE NONLYMPHOCYTIC LEUKEMIA WITH CYTOSINE-ARABINOSIDE.LEUKEMIA. VOL. 4. ISSUE 11. P. 790-796 | 67 | 92% | 18 |
4 | LATAGLIATA, R , PETTI, MC , MANDELLI, F , (1999) ACUTE MYELOID LEUKEMIA IN THE ELDERLY: "PER ASPERA AD ASTRA'?.LEUKEMIA RESEARCH. VOL. 23. ISSUE 7. P. 603 -613 | 57 | 75% | 11 |
5 | BAKER, WJ , ROYER, GL , WEISS, RB , (1991) CYTARABINE AND NEUROLOGIC TOXICITY.JOURNAL OF CLINICAL ONCOLOGY. VOL. 9. ISSUE 4. P. 679-693 | 62 | 77% | 147 |
6 | THOMAS, X , DOMBRET, H , (2007) TIMED-SEQUENTIAL CHEMOTHERAPY AS INDUCTION AND/OR CONSOLIDATION REGIMEN FOR YOUNGER ADULTS WITH ACUTE MYELOGENOUS LEUKEMIA.HEMATOLOGY. VOL. 12. ISSUE 1. P. 15-28 | 62 | 53% | 4 |
7 | KOEHL, U , HOLLATZ, G , ROHRBACH, E , VISSCHEDYK, K , CINATL, J , KORNHUBER, B , KREUTER, J , MUTSCHLER, E , SCHWABE, D , (2007) PHARMACOLOGY OF INTRACELLULAR CYTOSINE-ARABINOSIDE-5'-TRIPHOSPHATE IN MALIGNANT CELLS OF PEDIATRIC PATIENTS WITH INITIAL OR RELAPSED LEUKEMIA AND IN NORMAL LYMPHOCYTES.CANCER CHEMOTHERAPY AND PHARMACOLOGY. VOL. 60. ISSUE 4. P. 467-477 | 40 | 77% | 3 |
8 | LINDNER, L , OSTERMANN, H , HIDDEMANN, W , KIANI, A , WURFEL, M , ILLMER, T , KARSCH, C , PLATZBECKER, U , EHNINGER, G , SCHLEYER, E , (2008) ARAU ACCUMULATION IN PATIENTS WITH RENAL INSUFFICIENCY AS A POTENTIAL MECHANISM FOR CYTARABINE NEUROTOXICITY.INTERNATIONAL JOURNAL OF HEMATOLOGY. VOL. 88. ISSUE 4. P. 381-386 | 31 | 91% | 7 |
9 | KIMBY, E , NYGREN, P , GLIMELIUS, B , (2001) A SYSTEMATIC OVERVIEW OF CHEMOTHERAPY EFFECTS IN ACUTE MYELOID LEUKAEMIA.ACTA ONCOLOGICA. VOL. 40. ISSUE 2-3. P. 231 -252 | 57 | 55% | 48 |
10 | RUSTUM, YM , RAYMAKERS, RAP , (1992) 1-BETA-ARABINOFURANOSYLCYTOSINE IN THERAPY OF LEUKEMIA - PRECLINICAL AND CLINICAL OVERVIEW.PHARMACOLOGY & THERAPEUTICS. VOL. 56. ISSUE 3. P. 307-321 | 49 | 86% | 56 |
Classes with closest relation at Level 1 |